A biomarker-validated time scale in years of disease progression has identified early- and late-onset subgroups in sporadic Alzheimer’s disease

BACKGROUND: It is possible to calculate the number of years to the expected clinical onset (YECO) of autosomal-dominant Alzheimer’s disease (adAD). A similar time scale is lacking for sporadic Alzheimer’s disease (sAD). The purpose was to design and validate a time scale in YECO for patients with sA...

Descripción completa

Detalles Bibliográficos
Autores principales: Almkvist, Ove, Nordberg, Agneta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152764/
https://www.ncbi.nlm.nih.gov/pubmed/37131241
http://dx.doi.org/10.1186/s13195-023-01231-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152764/
https://www.ncbi.nlm.nih.gov/pubmed/37131241
http://dx.doi.org/10.1186/s13195-023-01231-8

Ejemplares similares